300841 康華生物
按盤價 
53.940 -0.880 (-1.605%)
53.940 -0.880 (-1.605%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.771 | 6.296 | 11.453 | 15.455 | 20.817 |
| 總資產報酬率 ROA (%) | 0.691 | 5.472 | 9.680 | 12.858 | 17.776 |
| 投入資產回報率 ROIC (%) | 0.747 | 5.986 | 10.832 | 14.665 | 20.247 | 邊際利潤分析 |
| 銷售毛利率 (%) | 90.979 | 92.035 | 94.203 | 93.453 | 93.562 |
| 營業利潤率 (%) | 17.210 | 22.306 | 32.634 | 36.555 | 47.383 |
| 息稅前利潤/營業總收入 (%) | 16.667 | 21.909 | 32.019 | 35.885 | 46.507 |
| 淨利潤/營業總收入 (%) | 15.867 | 18.875 | 27.841 | 32.282 | 41.339 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 109.460 | 103.895 | 119.201 | 107.690 | 97.339 |
| 價值變動淨收益/利潤總額(%) | 6.612 | 0.716 | -12.598 | -5.444 | 8.322 |
| 營業外收支淨額/利潤總額(%) | -0.460 | -0.049 | -0.056 | -0.456 | -0.250 | 償債能力分析 |
| 流動比率 (X) | 7.889 | 5.743 | 4.393 | 3.897 | 3.507 |
| 速動比率 (X) | 7.400 | 5.423 | 4.081 | 3.643 | 3.256 |
| 資產負債率 (%) | 8.742 | 11.779 | 14.403 | 16.516 | 17.122 |
| 帶息債務/全部投入資本 (%) | 0.648 | 3.573 | 5.013 | 5.086 | 4.473 |
| 股東權益/帶息債務 (%) | 15,191.613 | 2,674.032 | 1,887.391 | 1,859.192 | 2,130.120 |
| 股東權益/負債合計 (%) | 1,043.891 | 748.965 | 594.323 | 505.461 | 484.054 |
| 利息保障倍數 (X) | -35.884 | -56.689 | -53.596 | -71.230 | -61.344 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 631.243 | 390.035 | 340.596 | 307.828 | 264.297 |
| 存貨周轉天數 (天) | 843.278 | 616.223 | 759.877 | 570.290 | 500.834 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
